These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factorial designs: a graphical aid for choosing study designs accounting for interaction. Byth K; Gebski V Clin Trials; 2004; 1(3):315-25. PubMed ID: 16279257 [TBL] [Abstract][Full Text] [Related]
3. Trial designs for evaluating combination HIV prevention approaches. Chen YQ; Peng L; Wang Y; Appelmans E; Dasgupta S; Fleming TR HIV Res Clin Pract; 2020; 21(2-3):72-82. PubMed ID: 32698705 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the statistical power for multiple tests: a case study. Yeo A; Qu Y Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588 [TBL] [Abstract][Full Text] [Related]
6. Design, analysis and presentation of factorial randomised controlled trials. Montgomery AA; Peters TJ; Little P BMC Med Res Methodol; 2003 Nov; 3():26. PubMed ID: 14633287 [TBL] [Abstract][Full Text] [Related]
7. Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments. Jaki T; Vasileiou D Stat Med; 2017 Feb; 36(4):563-580. PubMed ID: 27804166 [TBL] [Abstract][Full Text] [Related]
8. Bayesian design and analysis of two x two factorial clinical trials. Simon R; Freedman LS Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445 [TBL] [Abstract][Full Text] [Related]
10. A two stage conditional power adaptive design adjusting for treatment by covariate interaction. Ayanlowo AO; Redden DT Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774 [TBL] [Abstract][Full Text] [Related]
11. Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions? Freidlin B; Korn EL J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954288 [TBL] [Abstract][Full Text] [Related]
13. A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints. Natarajan R; Turnbull BW; Slate EH; Clark LC Comput Methods Programs Biomed; 1996 Mar; 49(2):137-47. PubMed ID: 8735021 [TBL] [Abstract][Full Text] [Related]
14. A practical limit to trials needed in one-person randomized controlled experiments. Alemi R; Alemi F Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611 [TBL] [Abstract][Full Text] [Related]
15. Power and sample size when multiple endpoints are considered. Senn S; Bretz F Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404 [TBL] [Abstract][Full Text] [Related]
16. Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis. Wolbers M; Heemskerk D; Chau TT; Yen NT; Caws M; Farrar J; Day J Trials; 2011 Feb; 12():26. PubMed ID: 21288326 [TBL] [Abstract][Full Text] [Related]
17. Reporting of randomized factorial trials was frequently inadequate. Kahan BC; Tsui M; Jairath V; Scott AM; Altman DG; Beller E; Elbourne D J Clin Epidemiol; 2020 Jan; 117():52-59. PubMed ID: 31585174 [TBL] [Abstract][Full Text] [Related]